Suzuki A, Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Uemura K
Neurosurgical Service, Akita University Hospital, Japan.
No To Shinkei. 1996 May;48(5):449-57.
11C-methyl-L-methionine (C-11 Met)PET, CT and MR imaging were performed in eleven patients with malignant brain tumors before and after RT to evaluate the usefulness of positron emission tomography (PET) in monitoring tumor response to radiotherapy (RT). The subjects included five cases of intracranial malignant lymphoma (ICML) and six cases of glioma. C-11 Met uptake by the tumor (T) and the contralateral gray matter (NT) was calculated on the PET images. The mean T/NT ratio of the ICMLs and gliomas changed from 2.33 and 1.87, respectively, before RT to 1.31 and 1.58, respectively, after RT.No significant difference was found between the T/NT ratios before and after RT in either the ICMLs or the gliomas (t-test). We tentatively defined the minimum T/NT ratio, 1.2, as the threshold between tumor and nontumor regions. Tumors with a ratio of 1.2 or more were imaged as "hot" (MET) and coincided with CT or MR image lesions which were visualized as contrast-enhancing (CE) and low-density (LD) or high-intensity (HI). The relationships between PET, CT and MRI lesions were classified as follows: Type I (MET < or = CE), Type II [CE < MET < LD (HI)], Type III [LD(HI) < or = MET]. MET lesions extending regionally ( > 1 cm) beyond the respective CT or MR image lesions were designated "MET-extension" and LD (HI) lesions protruding ( > 1 cm) beyond the MET lesions were recorded as "LD (HI)-extension" on the integrated images. The type II pattern of the MET areas in all five cases of ICML before RT had changed to Type I in one case, Type III in one case and Type II in three cases, after RT, while the two Type II patterns and four Type III patterns of the gliomas had converted to four Type II and two Type III patterns. These findings indicate that gliomas tend to invade into areas of peritumoral edema more than ICMLs. There were two ICML MET-extension sites in the cortex before RT, as opposed to two in the cortex, one in the basal ganglia, one in the thalamus, and one in the corpus callosum among the gliomas. On follow-up CT or MR images MET-extension (75%) had converted to a CE or LD (HI) region. Four ICML LD (HI)-extension sites before RT were found in periventricular white matter, versus one in the cortex and three in the white matter among the gliomas. LD (HI)-extension appeared to represent vascular edema because it decreased or diminished after completion of therapy. Sequential analysis of integrated C-11 Met PET, CT and MR images is useful in detecting the extent of tumor infiltration by ICMLs and gliomas, particularly at an early stage, and for evaluating the effect of RT in the treatment of both.
对11例恶性脑肿瘤患者在放疗前后进行了11C-甲基-L-蛋氨酸(C-11 Met)PET、CT和MR成像,以评估正电子发射断层扫描(PET)在监测肿瘤对放射治疗(RT)反应中的作用。研究对象包括5例颅内恶性淋巴瘤(ICML)和6例胶质瘤。在PET图像上计算肿瘤(T)和对侧灰质(NT)的C-11 Met摄取量。ICML和胶质瘤的平均T/NT比值分别从放疗前的2.33和1.87变为放疗后的1.31和1.58。ICML和胶质瘤放疗前后的T/NT比值均未发现显著差异(t检验)。我们初步将最小T/NT比值1.2定义为肿瘤与非肿瘤区域的阈值。比值为1.2或更高的肿瘤被成像为“热”(MET),并与CT或MR图像上显示为强化(CE)和低密度(LD)或高强度(HI)的病变相符。PET、CT和MRI病变之间的关系分类如下:I型(MET≤CE),II型[CE<MET<LD(HI)],III型[LD(HI)≤MET]。在融合图像上,区域延伸超过各自CT或MR图像病变(>1 cm)的MET病变被指定为“MET延伸”,而突出超过MET病变(>1 cm)的LD(HI)病变被记录为“LD(HI)延伸”。放疗前所有5例ICML中MET区域的II型模式在放疗后1例变为I型,1例变为III型,3例仍为II型,而胶质瘤的2例II型模式和4例III型模式转变为4例II型和2例III型。这些发现表明,胶质瘤比ICML更倾向于侵入瘤周水肿区域。放疗前ICML有2个MET延伸部位位于皮质,而胶质瘤有2个位于皮质,1个位于基底节,1个位于丘脑,1个位于胼胝体。在随访CT或MR图像上,MET延伸(75%)已转变为CE或LD(HI)区域。放疗前ICML有4个LD(HI)延伸部位位于脑室周围白质,而胶质瘤有1个位于皮质,3个位于白质。LD(HI)延伸似乎代表血管性水肿,因为它在治疗完成后减少或消失。对融合的C-11 Met PET-CT和MR图像进行序列分析,有助于检测ICML和胶质瘤的肿瘤浸润范围,尤其是在早期阶段,并评估放疗对两者的治疗效果。